Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 27, 2022

SELL
$1.56 - $2.93 $43,680 - $82,040
-28,000 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$2.91 - $4.83 $29,100 - $48,300
10,000 Added 55.56%
28,000 $84,000
Q4 2020

Jan 25, 2021

BUY
$5.75 - $7.13 $28,750 - $35,650
5,000 Added 38.46%
18,000 $117,000
Q3 2020

Nov 06, 2020

BUY
$4.9 - $7.12 $63,700 - $92,560
13,000 New
13,000 $79,000
Q1 2018

Apr 19, 2018

SELL
$14.7 - $24.95 $148,705 - $252,394
-10,116 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$19.9 - $29.25 $50,725 - $74,558
-2,549 Reduced 20.13%
10,116 $235,000
Q3 2017

Nov 15, 2017

BUY
$15.1 - $19.25 $191,241 - $243,801
12,665
12,665 $234,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.